Ampersand Venture Management LLC

Mr. Parker is President and CEO of Cequent Pharmaceuticals, Inc. Prior to joining Cequent, Mr. Parker was a General Partner at Ampersand Ventures where he focused on the firm's Life Sciences activities. He has served as a director of numerous companies including ACLARA Biosciences, Tomah Products, VITEX, Magellan Biosciences, Dynex and Pentose Pharmaceuticals and as Chairman of Alexis, NOVEX, CoPharma, Huntington Laboratories, Protein Ingredient Technologies, Cyclis Pharmaceuticals, Nanodyne, Panacos Pharmaceuticals, AC Tech, Boston Heart Lab and TekCel. Prior to Ampersand, Mr. Parker spent fourteen years at AMAX, Inc. where he was President of Climax Performance Materials Corporation and Corporate Director of Research and Development. He holds B.S. and M.S. degrees from Columbia University.

Array

Dave joined Ampersand in 1994 and served as a General Partner from 1998 to 2007. Prior to joining Ampersand, Dave spent five years consulting at Bain and Mercer and four years in corporate lending at Bank of Boston. Currently, Dave serves as EVP and CFO of Victory Pharma, an Ampersand portfolio company, and as a director of Signature Genomic Labs. He holds a B.A. in Government and Economics from Dartmouth and an M.B.A. from Wharton.

Marc joined Ampersand in 2002 and served as General Partner through 2008. Prior to joining Ampersand he spent six years at Moldflow Corporation, an Ampersand portfolio company, where he was Chairman, President and CEO. Marc has nearly two decades of experience as a senior information technology executive, including serving as Senior VP of Marketing at Parametric Technology and in various positions at Nortel. Currently Marc serves as Chairman and CEO of RAND Worldwide, an Ampersand portfolio company. He holds an M.Eng. in Mechanical Engineering from Carleton University.

Stuart joined Ampersand in 1991, following three years of consulting experience at Bain and five years in manufacturing and engineering at Lever Brothers. Serving as the full-time CFO of ADFlex Solutions during the design and implementation of its turnaround, he has been a director of more than 10 companies including ADFlex, Northfield and Tomah. He currently sits on the board of Talecris. He holds a B.S. in Chemical Engineering from Columbia and an M.B.A. from Harvard Business School.

Todd joined Ampersand in 2005 to spearhead Ampersand's Direct-to-Entrepreneur (DTE) lead sourcing program by identifying and evaluating new investment opportunities. Previously, Todd was a Senior Associate at Summit Partners, a late-stage private equity firm, and a Financial Analyst in the investment banking division of Advest Inc. He currently serves on the board of LTI Lighting and a board observer at Chantest. Todd holds a B.A. in Economics from Bates College and an M.B.A. from Harvard Business School.

Array

Array

Array

Loretta joined Ampersand in 1998 with responsibility for all tax and general ledger records. Prior to Ampersand she was the Senior Tax Manager with Feeley & Driscoll. Loretta holds a B.A. from Regis College, an M.B.A. from Suffolk University, an M.S.T. from Bentley College, a J.D. from Suffolk University and a C.P.A. Certificate.

Thomas joined Ampersand in 2005 to support our Direct to Entrepreneur (DTE) lead sourcing program. Prior to Ampersand he was at Aleutian Capital Partners (ACP) where he was active in the Company's deal sourcing and deal diligence efforts. Thomas holds a M.B.A. from Pace University and B.A. in Economics from the University of Pretoria in South Africa.